Relevance of [18F]fluorodeoxyglucose positron emission tomography-positive lymph nodes after neoadjuvant chemotherapy for squamous cell oesophageal cancer

Evaluation of Response to Neoadjuvant Chemotherapy for Esophageal Cancer: PET Response Criteria in Solid Tumors Versus Response Evaluation Criteria in Solid Tumors

(2012) M. Yanagawa et al.   JOURNAL OF NUCLEAR MEDICINE

Clinical relevance of induction triplet chemotherapy for esophageal cancer invading adjacent organs

(2012) Hiroshi Miyata et al.   JOURNAL OF SURGICAL ONCOLOGY

FDG-PET Parameters as Prognostic Factor in Esophageal Cancer Patients: A Review

(2011) J. M. T. Omloo et al.   ANNALS OF SURGICAL ONCOLOGY

Role of positron emission tomography-computed tomography in predicting survival after neoadjuvant chemotherapy and surgery for oesophageal adenocarcinoma

(2011) R. S. Gillies et al.   BRITISH JOURNAL OF SURGERY

Preoperative Positron Emission Tomography/Computed Tomography Predicts Advanced Lymph Node Metastasis in Esophageal Squamous Cell Carcinoma Patients

(2011) Po-Kuei Hsu et al.   WORLD JOURNAL OF SURGERY

Prognostic Value of Endoscopic Biopsy Findings After Induction Chemoradiotherapy With and Without Surgery for Esophageal Cancer

(2010) Hiroshi Miyata et al.   ANNALS OF SURGERY

Utility of response evaluation to neo-adjuvant chemotherapy by 18F-fluorodeoxyglucose-positron emission tomography in locally advanced esophageal squamous cell carcinoma

(2010) Tomoki Makino et al.   SURGERY

The Number of Metastatic Lymph Nodes and the Ratio Between Metastatic and Examined Lymph Nodes Are Independent Prognostic Factors in Esophageal Cancer Regardless of Neoadjuvant Chemoradiation or Lymphadenectomy Extent

(2009) Christophe Mariette et al.   ANNALS OF SURGERY

[18F]-Fluorodeoxyglucose-Positron Emission Tomography for the Assessment of Histopathologic Response and Prognosis After Completion of Neoadjuvant Chemoradiation in Esophageal Cancer

(2009) Daniel Vallböhmer et al.   ANNALS OF SURGERY

18F-Fluorodeoxiglucose Positron Emission Tomography for the Evaluation of Neoadjuvant Therapy Response in Esophageal Cancer

(2009) Ángel C. Rebollo Aguirre et al.   ANNALS OF SURGERY

The clinical application of18F-fluorodeoxyglucose positron emission tomography to predict survival in patients with operable esophageal cancer

(2009) Hiroyuki Kato et al.   CANCER

Predicting Systemic Disease in Patients With Esophageal Cancer After Esophagectomy

(2008) Christian G. Peyre et al.   ANNALS OF SURGERY

Staging investigations for oesophageal cancer: a meta-analysis

(2008) E P M van Vliet et al.   BRITISH JOURNAL OF CANCER